cognitive cybersecurity intelligence

News and Analysis

FDA approves Leqembi, Alzheimer’s drug from Eisai and Biogen

WASHINGTON — U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.
The drug, Leqembi, is the first that’s been convincingly…

Source: www.modernhealthcare.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

Microsoft says Medusa-linked Storm-1175 is speeding ransomware attacks – csoonline.com

Microsoft says Medusa-linked Storm-1175 is speeding ransomware attacks csoonline.com

Iran-Linked Hackers Launch Password Spray Campaign Against Microsoft 365 Tenants in Middle East

Microsoft 365 tenants in the Middle East are facing a new password spray campaign tied to an Iran-linked threat actor. Rather than starting with malware

Data Masking Gaps That Could Expose Your Organization

Organizations collect and store huge amounts of sensitive data, customer details, financial records, login credentials, and more. Protecting this data is not just important; it’s

Australia's most decorated veteran charged with Afghanistan war crimes

Australia’s most decorated living veteran has been charged with allegedly killing five unarmed Afghans between 2009 and 2012.

News and Analysis

FDA approves Leqembi, Alzheimer’s drug from Eisai and Biogen

Subscribe to newsletter

More Posts

Microsoft says Medusa-linked Storm-1175 is speeding ransomware attacks – csoonline.com

Iran-Linked Hackers Launch Password Spray Campaign Against Microsoft 365 Tenants in Middle East

Data Masking Gaps That Could Expose Your Organization

Australia's most decorated veteran charged with Afghanistan war crimes

Products

Solutions

Healthcare cybersecurity

Healthcare Threat Intelligence

Use Cases

News and Analysis

Insights

Company